Finoriq research workspace
Generate Biomedicines, Inc. (GENB) SEC Filings & Filing Highlights
In additional, it develops Generate Platform, designed to be a therapeutic area and protein. Review GENB SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.
- Company
- Generate Biomedicines, Inc. (GENB)
- Ticker
- GENB
- Market Cap
- $1.7B
- Latest Price
- $13.63
- Industry
- Biotech & Pharma
Generate Biomedicines, Inc. (GENB) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Generate Biomedicines, Inc. (GENB).
| Event | Form | Date |
|---|---|---|
| Generate Biomedicines, IncReports First Quarter 2026 Financial Results and Provides Business Update | 8-K2.02 | 2026-05-07 |
| Generate Biomedicines, Inc.: Governance or capital structure updateAs previously disclosed in the Registration Statement on Form S-1, as amended (File No. 333-293204) (the “Registration Statement”), of Gene... | 8-K5.03 | 2026-03-02 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.